Literature DB >> 11884537

Capsid-specific cytotoxic T lymphocytes recognize three distinct H-2D(b)-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles.

Michael A Lyman1, Hee-Gu Lee, Bong Su Kang, Hee-Kap Kang, Byung S Kim.   

Abstract

The role of virus-specific cytotoxic T lymphocytes (CTL) in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease, a viral model for multiple sclerosis, is not yet clear. To investigate the specificity and function of CTL generated in response to TMEV infection, we generated a panel of overlapping 20-mer peptides encompassing the entire capsid and leader protein region of the BeAn strain of TMEV. Binding of these peptides to H-2K(b) and H-2D(b) class I molecules of resistant mice was assessed using RMA-S cells. Several peptides displayed significant binding to H-2K(b), H-2D(b), or both. However, infiltrating cytotoxic T cells in the central nervous system of virus-infected mice preferentially lysed target cells pulsed with VP2(111-130/121-140) or VP2(121-130), a previously defined CTL epitope shared by the DA strain of TMEV and other closely related cardioviruses. In addition, at a high effector-to-target cell ratio, two additional peptides (VP2(161-180) and VP3(101-120)) sensitized target cells for cytolysis by infiltrating T cells or splenic T cells from virus-infected mice. The minimal epitopes within these peptides were defined as VP2(165-173) and VP3(110-120). Based on cytokine profiles, CTL specific for these subdominant epitopes are Tc2, in contrast to CTL for the immunodominant epitope, which are of the Tc1 type. Interestingly, CTL function towards both of these subdominant epitopes is restricted by the H-2D molecule, despite the fact that these epitopes bind both H-2K and H-2D molecules. This skewing toward an H-2D(b)-restricted response may confer resistance to TMEV-induced demyelinating disease, which is known to be associated with the H-2D genetic locus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884537      PMCID: PMC136020          DOI: 10.1128/jvi.76.7.3125-3134.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Extracellular processing and presentation of a 69-mer synthetic polypetide to MHC class I-restricted T cells.

Authors:  G Eberl; J Renggli; Y Men; M A Roggero; J A Lopez; G Corradin
Journal:  Mol Immunol       Date:  1999-02       Impact factor: 4.407

2.  Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.

Authors:  A J Johnson; M K Njenga; M J Hansen; S T Kuhns; L Chen; M Rodriguez; L R Pease
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Perforin-dependent neurologic injury in a viral model of multiple sclerosis.

Authors:  P D Murray; D B McGavern; X Lin; M K Njenga; J Leibowitz; L R Pease; M Rodriguez
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

Review 4.  Hierarchies of antigen-specific cytotoxic T-cell responses.

Authors:  A Gallimore; H Hengartner; R Zinkernagel
Journal:  Immunol Rev       Date:  1998-08       Impact factor: 12.988

Review 5.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  A spontaneous low-pathogenic variant of Theiler's virus contains an amino acid substitution within the predominant VP1(233-250) T-cell epitope.

Authors:  B S Kim; R L Yauch; Y Y Bahk; J A Kang; M C Dal Canto; C K Hall
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading.

Authors:  S D Miller; C L Vanderlugt; W S Begolka; W Pao; R L Yauch; K L Neville; Y Katz-Levy; A Carrizosa; B S Kim
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

8.  Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.

Authors:  J Wang; S Saffold; X Cao; J Krauss; W Chen
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

9.  Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response.

Authors:  R L Yauch; J P Palma; H Yahikozawa; C S Koh; B S Kim
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Endogenous myelin basic protein inactivates the high avidity T cell repertoire.

Authors:  O S Targoni; P V Lehmann
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  22 in total

1.  Differences in avidity and epitope recognition of CD8(+) T cells infiltrating the central nervous systems of SJL/J mice infected with BeAn and DA strains of Theiler's murine encephalomyelitis virus.

Authors:  Bong-Su Kang; Michael A Lyman; Byung S Kim
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

3.  Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease.

Authors:  Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neurovirol       Date:  2012-03-09       Impact factor: 2.643

4.  Preferential induction of protective T cell responses to Theiler's virus in resistant (C57BL/6 x SJL)F1 mice.

Authors:  Young-Hee Jin; Hyun Seok Kang; Mani Mohindru; Byung S Kim
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

Review 5.  Effect of the innate immune response on development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  Julie K Olson
Journal:  J Neurovirol       Date:  2014-07-01       Impact factor: 2.643

6.  A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigen.

Authors:  Michael P Bell; Danielle N Renner; Aaron J Johnson; Kevin D Pavelko
Journal:  Viral Immunol       Date:  2014-07-15       Impact factor: 2.257

7.  A translatable molecular approach to determining CD8 T-cell epitopes in TMEV infection.

Authors:  Jeremiah McDole; Georgette Suidan; Erin Boespflug; Jie Cheng; Yi Chen; Istvan Pirko; Aaron Johnson
Journal:  Hum Immunol       Date:  2008-09-24       Impact factor: 2.850

8.  Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.

Authors:  Pamela A Carpentier; Meghann Teague Getts; Stephen D Miller
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

9.  Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice.

Authors:  Jinjong Myoung; Young Yil Bahk; Hyun Seok Kang; Mauro C Dal Canto; Byung S Kim
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

Review 10.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.